Perioperative Medicine and Intensive Care, Karolinska University Hospital, Solna, Stockholm, Sweden.
Section of Anesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, 171 65, Solna, Stockholm, Sweden.
Sci Rep. 2024 Jan 2;14(1):20. doi: 10.1038/s41598-023-50508-3.
Opioid misuse has become a serious public health problem. Patients admitted to cardio-thoracic critical care are usually exposed to opioids, but the incidence and effects of chronic opioid use are not known. The primary objective was to describe opioid use after admission to a cardio-thoracic intensive care unit. Secondary objectives were to identify factors associated with chronic opioid usage and analyze risk of death. This cohort study included all cardio-thoracic ICU care episodes in Sweden between 2010 and 2018. Among the 34,200 patients included in the final study cohort, 4050 developed persistent opioid use after ICU care. Younger age, preadmission opioid use, female sex, presence of comorbidities and earlier year of ICU admission were all found to be associated with persistent opioid use. The adjusted hazard ratio for mortality between 6 and 18 months after admission among individuals with persistent opioid use was 2.2 (95% CI 1.8-2.6; P < 0.001). For opioid-naïve patients before ICU admission, new onset of chronic opioid usage was significant during the follow-up period of 24 months. Despite the absence of conclusive evidence supporting extended opioid treatment, the average opioid consumption remains notably elevated twelve months subsequent to cardio-thoracic ICU care.
阿片类药物滥用已成为严重的公共卫生问题。入住心胸重症监护病房的患者通常会接触到阿片类药物,但慢性阿片类药物使用的发生率和影响尚不清楚。主要目的是描述入住心胸重症监护病房后的阿片类药物使用情况。次要目的是确定与慢性阿片类药物使用相关的因素,并分析死亡风险。这项队列研究包括了 2010 年至 2018 年期间在瑞典的所有心胸重症监护病房的护理案例。在最终的研究队列中,34200 名患者中有 4050 名在 ICU 护理后出现持续的阿片类药物使用。年龄较小、入院前阿片类药物使用、女性、合并症存在以及 ICU 入院较早均与持续的阿片类药物使用相关。在 ICU 入院后 6 至 18 个月,持续使用阿片类药物的个体的死亡调整风险比为 2.2(95%CI 1.8-2.6;P<0.001)。对于 ICU 入院前没有阿片类药物使用史的患者,在 24 个月的随访期间,慢性阿片类药物使用新发病例显著增加。尽管没有确凿的证据支持延长阿片类药物治疗,但心胸重症监护病房治疗后 12 个月内阿片类药物的平均消耗量仍然明显升高。